Literature DB >> 34209556

Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1.

Carla Zannella1, Rosa Giugliano1, Annalisa Chianese1, Carmine Buonocore2,3, Giovanni Andrea Vitale3, Giuseppina Sanna4, Federica Sarno5, Aldo Manzin4, Angela Nebbioso5, Pasquale Termolino6, Lucia Altucci5,7, Massimiliano Galdiero1, Donatella de Pascale3, Gianluigi Franci8.   

Abstract

Vitis vinifera represents an important and renowned source of compounds with significant biological activity. Wines and winery bioproducts, such as grape pomace, skins, and seeds, are rich in bioactive compounds against a wide range of human pathogens, including bacteria, fungi, and viruses. However, little is known about the biological properties of vine leaves. The aim of this study was the evaluation of phenolic composition and antiviral activity of Vitis vinifera leaf extract against two human viruses: the Herpes simplex virus type 1 (HSV-1) and the pandemic and currently widespread severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). About 40 phenolic compounds were identified in the extract by HPLC-MS/MS analysis: most of them were quercetin derivatives, others included derivatives of luteolin, kaempferol, apigenin, isorhamnetin, myricetin, chrysoeriol, biochanin, isookanin, and scutellarein. Leaf extract was able to inhibit both HSV-1 and SARS-CoV-2 replication in the early stages of infection by directly blocking the proteins enriched on the viral surface, at a very low concentration of 10 μg/mL. These results are very promising and highlight how natural extracts could be used in the design of antiviral drugs and the development of future vaccines.

Entities:  

Keywords:  HSV-1; LC-MS; SARS-CoV-2; Vitis vinifera; antimicrobial; antiviral; flavonoids; leaf extract; molecular networking; natural extract

Mesh:

Substances:

Year:  2021        PMID: 34209556     DOI: 10.3390/v13071263

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  47 in total

1.  The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells.

Authors:  Yaoh-Shiang Lin; Su-Feng Chen; Chia-Lin Liu; Shin Nieh
Journal:  J Oral Pathol Med       Date:  2011-11-21       Impact factor: 4.253

Review 2.  Antibacterial, antiviral, and antifungal properties of wines and winery byproducts in relation to their flavonoid content.

Authors:  Mendel Friedman
Journal:  J Agric Food Chem       Date:  2014-06-19       Impact factor: 5.279

Review 3.  Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives.

Authors:  Annalisa Chianese; Biagio Santella; Annalisa Ambrosino; Debora Stelitano; Luca Rinaldi; Massimiliano Galdiero; Carla Zannella; Gianluigi Franci
Journal:  Cancers (Basel)       Date:  2021-06-02       Impact factor: 6.639

4.  Antioxidant polyphenols of Madeira sorrel (Rumex maderensis): How do they survive to in vitro simulated gastrointestinal digestion?

Authors:  Vítor Spínola; Eulogio J Llorent-Martínez; Paula C Castilho
Journal:  Food Chem       Date:  2018-03-27       Impact factor: 7.514

5.  Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model.

Authors:  Alexander Schlachterman; Felix Valle; Kristin M Wall; Nicolas G Azios; Linette Castillo; Lymar Morell; A Valance Washington; Luis A Cubano; Surangani F Dharmawardhane
Journal:  Transl Oncol       Date:  2008-03       Impact factor: 4.243

6.  Grape seed proanthocyanidins inhibit the invasive potential of head and neck cutaneous squamous cell carcinoma cells by targeting EGFR expression and epithelial-to-mesenchymal transition.

Authors:  Qian Sun; Ram Prasad; Eben Rosenthal; Santosh K Katiyar
Journal:  BMC Complement Altern Med       Date:  2011-12-21       Impact factor: 3.659

7.  In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2.

Authors:  Anisha S Jain; P Sushma; Chandan Dharmashekar; Mallikarjun S Beelagi; Shashanka K Prasad; Chandan Shivamallu; Ashwini Prasad; Asad Syed; Najat Marraiki; Kollur Shiva Prasad
Journal:  Saudi J Biol Sci       Date:  2020-11-17       Impact factor: 4.219

8.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

9.  Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2).

Authors:  Chaima Mouffouk; Soumia Mouffouk; Sara Mouffouk; Leila Hambaba; Hamada Haba
Journal:  Eur J Pharmacol       Date:  2020-11-27       Impact factor: 4.432

10.  Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches.

Authors:  Hossam M Abdallah; Ali M El-Halawany; Alaa Sirwi; Amr M El-Araby; Gamal A Mohamed; Sabrin R M Ibrahim; Abdulrahman E Koshak; Hani Z Asfour; Zuhier A Awan; Mahmoud A Elfaky
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-04
View more
  8 in total

Review 1.  Next Generation Ingredients Based on Winemaking By-Products and an Approaching to Antiviral Properties.

Authors:  Guillermo Pascual; María Dolores López; Marisol Vargas; Mario Aranda; Juan Antonio Cañumir
Journal:  Foods       Date:  2022-05-29

2.  Natural Formulations Based on Olea europaea L. Fruit Extract for the Topical Treatment of HSV-1 Infections.

Authors:  Stefania Cometa; Carla Zannella; Francesco Busto; Anna De Filippis; Gianluigi Franci; Massimiliano Galdiero; Elvira De Giglio
Journal:  Molecules       Date:  2022-07-02       Impact factor: 4.927

Review 3.  The Impact of COVID-19 Pandemic on Seafood Safety and Human Health.

Authors:  Nikheel Bhojraj Rathod; Nariman Elabed; Fatih Özogul; Joe M Regenstein; Charis M Galanakis; Sulaiman Omar Aljaloud; Salam A Ibrahim
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

4.  Computational guided identification of potential leads from Acacia pennata (L.) Willd. as inhibitors for cellular entry and viral replication of SARS-CoV-2.

Authors:  James H Zothantluanga; Neelutpal Gogoi; Anshul Shakya; Dipak Chetia; H Lalthanzara
Journal:  Futur J Pharm Sci       Date:  2021-10-09

5.  Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19.

Authors:  Junyuan Cao; Yang Liu; Minmin Zhou; Siqi Dong; Yuxia Hou; Xiaoying Jia; Xiaohao Lan; Yueli Zhang; Jiao Guo; Gengfu Xiao; Wei Wang
Journal:  Viruses       Date:  2022-02-08       Impact factor: 5.048

6.  Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial.

Authors:  Ramtin Hajibeygi; Sayid Mahdi Mirghazanfari; Naseh Pahlavani; Abduladheem Turki Jalil; Shadia Hamoud Alshahrani; Jasur Alimdjanovich Rizaev; Saeid Hadi; Vahid Hadi; Nafiseh Hosseini Yekta
Journal:  Eur J Integr Med       Date:  2022-08-20       Impact factor: 1.813

7.  Promising Antiviral Activity of Agrimonia pilosa Phytochemicals against Severe Acute Respiratory Syndrome Coronavirus 2 Supported with In Vivo Mice Study.

Authors:  Nashwah G M Attallah; Aya H El-Kadem; Walaa A Negm; Engy Elekhnawy; Thanaa A El-Masry; Elshaymaa I Elmongy; Najla Altwaijry; Ashwag S Alanazi; Gadah Abdulaziz Al-Hamoud; Amany E Ragab
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-16

8.  Antiviral Activity of the Rhamnolipids Mixture from the Antarctic Bacterium Pseudomonas gessardii M15 against Herpes Simplex Viruses and Coronaviruses.

Authors:  Rosa Giugliano; Carmine Buonocore; Carla Zannella; Annalisa Chianese; Fortunato Palma Esposito; Pietro Tedesco; Anna De Filippis; Massimiliano Galdiero; Gianluigi Franci; Donatella de Pascale
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.